The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

Scientists say HHS’ decision to defund mRNA vaccine research will leave the country less prepared for pandemics, and make it ...

Multiple Massachusetts-based vaccine companies, including Moderna, are affected by U.S. Health and Human Services Secretary ...

Illinois researchers, including some working on vaccines for cancer and rare diseases, worry the federal government turning ...

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be ...

That kind of shot was first used during the Covid-19 pandemic, but the health secretary has been sharply critical of the ...

The average short interest in the S&P 500 Health Care Index Sector (XLV) dipped slightly in July to 1.95% from 1.96% in June.

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...

HHS Secretary Robert F. Kennedy Jr. says the federal government is calling off around $500 million worth of vaccine ...

Shares of the biotech Moderna were up on Wednesday, as the Trump administration’s shifting position on messenger RNA-based ...

Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the ...

We recently published 10 Stocks Jim Cramer Mentioned As He Talked About “Love Lost” Between Microsoft & OpenAI. Moderna, Inc. (NASDAQ:MRNA) is one of the stocks Jim Cramer recently discussed.